UnitedHealth Group Incorporated (NYSE:UNH) CFO John F. Rex Sells 13,183 Shares of Stock

UnitedHealth Group Incorporated (NYSE:UNHGet Rating) CFO John F. Rex sold 13,183 shares of the company’s stock in a transaction that occurred on Friday, July 29th. The shares were sold at an average price of $541.53, for a total value of $7,138,989.99. Following the completion of the sale, the chief financial officer now owns 141,508 shares in the company, valued at $76,630,827.24. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

UnitedHealth Group Trading Up 0.2 %

NYSE UNH opened at $542.34 on Friday. The firm has a market capitalization of $508.81 billion, a P/E ratio of 28.32, a PEG ratio of 1.64 and a beta of 0.77. The business has a fifty day simple moving average of $502.80 and a 200 day simple moving average of $497.08. UnitedHealth Group Incorporated has a 12 month low of $383.12 and a 12 month high of $553.29. The company has a current ratio of 0.77, a quick ratio of 0.78 and a debt-to-equity ratio of 0.60.

UnitedHealth Group (NYSE:UNHGet Rating) last released its quarterly earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 EPS for the quarter, beating analysts’ consensus estimates of $5.24 by $0.33. UnitedHealth Group had a return on equity of 25.45% and a net margin of 5.95%. The business had revenue of $80.33 billion during the quarter, compared to analyst estimates of $79.68 billion. During the same period in the prior year, the firm posted $4.70 EPS. UnitedHealth Group’s quarterly revenue was up 12.6% compared to the same quarter last year. On average, analysts predict that UnitedHealth Group Incorporated will post 21.84 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 28th. Stockholders of record on Monday, June 20th were given a dividend of $1.65 per share. The ex-dividend date was Thursday, June 16th. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.45. This represents a $6.60 annualized dividend and a dividend yield of 1.22%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 34.46%.

Institutional Investors Weigh In On UnitedHealth Group

Several large investors have recently made changes to their positions in the business. Outfitter Financial LLC purchased a new stake in UnitedHealth Group in the 4th quarter worth about $25,000. Urban Wealth Management LLC purchased a new stake in UnitedHealth Group in the 2nd quarter worth about $29,000. Advocacy Wealth Management Services LLC increased its holdings in UnitedHealth Group by 75.8% in the 1st quarter. Advocacy Wealth Management Services LLC now owns 58 shares of the healthcare conglomerate’s stock worth $30,000 after acquiring an additional 25 shares during the last quarter. Cascade Investment Advisors Inc. increased its holdings in UnitedHealth Group by 100.0% in the 1st quarter. Cascade Investment Advisors Inc. now owns 60 shares of the healthcare conglomerate’s stock worth $31,000 after acquiring an additional 30 shares during the last quarter. Finally, Rothschild & Co Wealth Management UK Ltd purchased a new stake in UnitedHealth Group in the 2nd quarter worth about $31,000. 87.48% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several analysts recently commented on the company. Wells Fargo & Company reduced their target price on UnitedHealth Group from $613.00 to $612.00 and set an “overweight” rating on the stock in a report on Wednesday, May 25th. SVB Leerink upped their target price on UnitedHealth Group from $600.00 to $625.00 and gave the company an “outperform” rating in a report on Monday, July 18th. Deutsche Bank Aktiengesellschaft increased their price target on UnitedHealth Group from $549.00 to $556.00 in a report on Tuesday, July 19th. Cowen increased their price target on UnitedHealth Group from $512.00 to $596.00 in a report on Monday, April 18th. Finally, BMO Capital Markets increased their price target on UnitedHealth Group from $600.00 to $610.00 in a report on Wednesday, July 20th. Three analysts have rated the stock with a hold rating, sixteen have assigned a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $582.50.

About UnitedHealth Group

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

See Also

Insider Buying and Selling by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.